Talon Therapeutics Inc (TLON1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
2207 BRIDGEPOINTE PARKWAY, SUITE 250, SAN MATEO, CA 94404
650-588-6404

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 2.97 Million Shares Outstanding19.04 Million Avg 30-day Volume 319.08 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue0.0 Debt to Equity-1.6308 EBITDA-20.887 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value265.475 Million
Current Ratio0.556 EPS Growth0 Quick Ratio0.482
1 Yr BETA 0.298 52-week High/Low 0.0 / Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score-244.3392 Free Cash Flow to Firm 0
View SEC Filings from TLON1 instead.

View recent insider trading info

Funds Holding TLON1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TLON1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MAIER PAUL V

  • Director
No longer subject to file 2013-07-17 0

PIEN HOWARD H

  • Director
No longer subject to file 2013-07-17 0

CARLSON CRAIG W CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2013-07-17 0

ROSENBERG LEON E

  • Director
No longer subject to file 2013-07-17 0

DEZAO THOMAS VP, COMM. OPER. & PLANNING

  • Officer
No longer subject to file 2013-07-17 0

DEITCHER STEVEN R PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2013-07-17 0

FURST HOWARD P.

  • Director
No longer subject to file 2013-07-17 0

SPIEGEL ROBERT J.

  • Director
No longer subject to file 2013-07-17 0

GHARIB SAMIR M. CONTROLLER, DIRECT. OF FINANCE

  • Officer
No longer subject to file 2013-07-17 0

WARBURG PINCUS & CO.

WARBURG PINCUS PRIVATE EQUITY X, L.P.

WARBURG PINCUS X PARTNERS, L.P.

WARBURG PINCUS X, L.P.

WARBURG PINCUS X LLC

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • Director
  • 10% Owner
No longer subject to file 2013-07-16 0

WEATHERMAN ELIZABETH H

  • Director
No longer subject to file 2013-07-16 0

GONZALO CECILIA

  • Director
0 2013-01-25 0

LEFF JONATHAN S

  • Director
0 2012-02-17 0

FERRER ANDREW

  • Director
0 2012-02-17 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD PRIVATE DESIGN FUND L P

DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

DEERFIELD MANAGEMENT CO /NY

DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

  • Director
  • 10% Owner
  • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
2,951,152 2011-09-26 0

DESILVA NISHAN M

  • Director
0 2011-04-01 0

NIELSEN TYLER MARSHALL CONTROLLER

  • Officer
0 2010-12-31 0

LEFF JONATHAN S

DESILVA NISHAN M

FERRER ANDREW

  • Director
0 2010-06-07 0

WEISER MICHAEL

  • Director
561,667 2010-02-16 0

WIESINGER LINDA

  • Director
6,000 2010-02-16 0

HAGEY ANNE E VP, CHIEF MEDICAL OFFICER

  • Officer
0 2010-02-16 0

BELLDEGRUN ARIE

  • Director
0 2009-02-24 0

IPARRAGUIRRE JOHN VICE PRESIDENT & CFO

  • Officer
16,026 2009-02-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments